Find Tenders for Medical equipments, pharmaceuticals and personal care products

Polymer Products 2026

Description: This framework is for Polymer Products including and not limited to those listed below. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of PS15,853,000.00 to PS16,800,000.00 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. Estimated value over the total Framework Agreement term (including any extension options),is approximately PS67,200,000.00 The Framework Agreement will be between NHS Supply Chain and the Supplier. The intended Lot Structure for this procurement is set out as follows: * Lot 1 Core Aprons * Lot 2 Clinical and Offensive Waste Bags * Lot 3 Specimen / Resealable Bags * Lot 4 PEVA Body Bags * (read more...)

Summary: The NHS Supply Chain, operating as Supply Chain Coordination Limited, is currently initiating the tender stage for a significant public procurement process titled "Polymer Products 2026." This tender, which falls within the goods category, specifically targets the procurement of various polymer products such as aprons, waste bags, and body bags, essential for healthcare settings across the United Kingdom. With headquarters located in London, Supply Chain Coordination Limited is overseeing this process. The estimated total value of this procurement is approximately £67,200,000 over the course of the framework agreement. The open procedure procurement method is being utilised, and key dates include the tender submission deadline set for 18th May 2026, and the enquiry period ending on 8th May 2026, with the anticipated contract start date on 31st October 2026.

Transitional Drugs 7

Description: The provision of Drugs which have lost or are shortly to lose exclusivity, namely Eculizumab; Icatibant; Nintedanib; Omalizumab; Tocilizumab

Summary: The NHS Wales Shared Services Partnership - Procurement Services, hosted by Velindre NHS Trust, has initiated an active tender process titled "Transitional Drugs 7." This procurement is centred around the provision of pharmaceutical products, including drugs such as Eculizumab and Tocilizumab, that have lost or are set to lose market exclusivity. The procurement method employed is an open procedure, allowing for broad participation. The tender is valued at approximately £64.28 million gross and is categorised under goods procurement within the pharmaceutical industry. It is expected to be fulfilled throughout Wales, with the contract period commencing on 1st July 2026 and potentially extending until 30th June 2030, considering the renewal options. Key deadlines include an expression of interest deadline on 29th May 2026, with the award period concluding on 8th June 2026.

Property Works

Description: The Property Works Dynamic Market will be a solution for the procurement of property maintenance and improvement. From initial assessment and compliance through to the installation of modern, sustainable infrastructure, each lot will address a specific facet of asset management.

Summary: The procurement process initiated by PLACES FOR PEOPLE GROUP LIMITED involves a comprehensive property maintenance and improvement initiative titled "Property Works". This procurement, under the planning stage, is set to cover a wide range of services such as building services, energy and related services, and construction work, among others, to be executed across the United Kingdom, Guernsey, Isle of Man, Jersey, and Gibraltar. The procurement is conducted through an open procedure, and the tender period is expected to close on 30th June 2026, followed by an award period ending on 31st July 2026. The initiative focuses on various industry categories, including energy efficiency and construction, positioning itself under the overarching category of works.

Framework for the Supply of Solutions, Reagents and Serums

Description: NHS Blood and Transplant (NHSBT) have a requirement for the Supply of Solutions. NHSBT Laboratories including Tissue and Eye Services (TES), RCI, Donor Testing, H&I, CMT, CBC and IBGRL are specialist functions of National Health Service Blood and Transplant (NHSBT). The solutions are used for patient and donor testing and within the manufacture of Tissue Grafts and reagents used for blood grouping and patient testing. NHSBT are looking to create a Framework Agreement and intends to award the framework agreement to the two highest-ranked Tenderers, per Lot, following completion of the evaluation process. Suppliers can bid for and be awarded multiple Lots. This requirement will cover the following solutions: * Phosphate Buffered Saline Solution (PBSS) and Concentrate (PBSC) * Low Ionic Strength Solution (LISS) * Cambridge Antibiotic Solution (read more...)

Summary: NHS Blood and Transplant, located at 500 North Bristol Park, Bristol, is overseeing a procurement process for a framework agreement titled "Framework for the Supply of Solutions, Reagents and Serums". This opportunity falls under the goods category with a focus on chemical reagents, applicable across the United Kingdom. Currently at the tender stage, the procurement is being conducted through an open procedure, with submissions accepted in English via electronic means. Key dates include the enquiry period closing on 24th April 2026 and the tender period concluding on 18th May 2026, leading up to an award period ending on 5th June 2026.

Design, Furniture and Appliances 3

Description: NHS Shared Business Services Limited (NHS SBS) intends to put in place its 3rd generation Framework for the provision of design, furniture and appliances to be used by Approved Organisations for the following proposed Lots, which are under consideration during this preliminary market engagement: Lot 1.1 - Clinical and Healthcare Environment Design Provision of consultancy services for clinical and healthcare environment, including planning and design, utilisation analysis, and space planning. Lot 1.2 - Consultancy, Design and Turnkey Provision of end-to-end consultancy interior design, space planning, and turnkey delivery services. Lot 2.1 - Office and Residential Furniture Provision of design, supply, delivery, and installation of a variety of office and residential furniture. Lot 2.2 - Office and Residential - Hire, Lease and Subscription Provision of hire, lease and subscription (read more...)

Summary: NHS Shared Business Services Limited is currently in the planning stage of establishing a Framework Agreement under the Procurement Act 2023 for the "Design, Furniture and Appliances 3" project. This procurement, aligned with industry categories such as medical furniture and specialty design services, aims to cover multiple lots including consulting and turnkey services, furniture supply, and environmental graphics. With a budget allocation reaching up to £80 million net, the initiative spans across various regions, including the United Kingdom, Guernsey, Isle of Man, and Jersey. Currently, preliminary market engagement is underway, with interested parties required to submit the Preliminary Market Engagement Questionnaire by midday 14 May 2026. This procurement will employ an eSourcing system via SAP Ariba for subsequent activities, emphasising the need for valid registration credentials.

UKHSA Rapid diagnostics for Neisseria meningitidis- Preliminary Market Engagement Notice

Description: The UK Health Security Agency (UKHSA) is looking to gather information on diagnostics currently available on the UK market to test for Neisseria meningitidis and/or Neisseria meningitidis Serogroup B specifically. This is not a call for competition, but a market research activity aimed at gathering insights from suppliers to understand the current supplier landscape and market capabilities. Interested suppliers are invited to complete the Microsoft form, included in the documentation available via Atamis eSourcing portal, no later than 11:59 21/04/2026. Full details are included in the Preliminary Market Engagement Notice and questionnaire on the Portal https://atamis-1928.my.site.com/s/Welcome

Summary: The UK Health Security Agency (UKHSA), acting under the Secretary of State for Health and Social Care, is spearheading a public procurement process to engage with suppliers in the market for rapid diagnostics for Neisseria meningitidis. This initiative, focused on gathering market insights rather than competitive bids, is at the planning stage. The agency's office is based in London, and it welcomes responses from suppliers across the UK. Interested parties must complete a questionnaire available via the Atamis eSourcing portal by 21 April 2026 at 11:59 PM. This engagement seeks to understand the supplier landscape and capabilities, aligning with the main procurement category of goods, including diagnostic kits and medical consumables.

Walking Aids

Description: Walking Aids pre-market engagement notice.

Summary: The NHS Wales Shared Services Partnership-Procurement Services, hosted by Velindre University NHS Trust, is currently in the planning stage of a public procurement process for the provision of walking aids. This procurement, titled "Walking Aids," falls under the industry category of medical equipment and is expected to cover the entire UK. An engagement meeting is scheduled for 23rd April 2026 to allow interested suppliers to inquire about the tender process. The tender, which is set to commence on 1st April 2027 and run through to 31st March 2030, with potential extensions up to 31st March 2032, is expected to be advertised by 30th June 2026.

The Supply of Dermal Regeneration Products for use in Theatres

Description: WBF0355 - The Supply of Dermal Regeneration Products for use in Theatres

Summary: The University Hospitals of North Midlands NHS Trust is seeking suppliers for "The Supply of Dermal Regeneration Products for use in Theatres," targeting the medical consumables category. Situated in Stoke on Trent, this procurement process falls under the central government public authority category and is currently in the tender stage. Interested parties must submit their proposals by the tender period deadline on 22 April 2026 at 13:00 BST, with any enquiries to be made before 15 April 2026. The procurement method in use is open competition, suited for projects below the threshold, and offers opportunities via electronic submission.

Musculoskeletal Surgical 2028 (Total Orthopaedic Solutions)

Description: Products and services used in Orthopaedic, Trauma and Spine procedures, including medical devices (including Orthopaedic specific equipment such as power tools), equipment management services and orthopaedic specific services. Note: For future tenders the following requirements will apply: * ISO Certification: Tenderers must have ISO 9001: 2015 or BS EN ISO 13485:2016 or Medical Device Single Audit Program (MDAP) accredited by the United Kingdom Accreditation Service (or international equivalent) to cover all segments of the Tenderer's and the product's supply chain. This should include, but not be limited to, sales, manufacturing, storage and distribution ('ISO Certification'). Link for acceptable alternatives https://iaf.nu/en/accreditation-bodies/ ('Notified Bodies'). * CE Certification and Declaration of Conformity certificates are required where applicable to be presented at submission stage of the tender. * Modern Slavery for Tenderers (read more...)

Summary: The public procurement process for the "Musculoskeletal Surgical 2028 (Total Orthopaedic Solutions)" project is currently in the planning stage, spearheaded by Supply Chain Coordination Limited, a sub-central government public authority located in London, United Kingdom. The procurement is focused on supplying goods and services related to Orthopaedic, Trauma, and Spine procedures, with significant product categorizations like orthopaedic implants and surgical instruments. The total estimated contract value is £3.6 billion. Key engagement milestones include online activities in May 2026, in-person activities in June 2026, and further online discussions in September 2026. Interested suppliers are encouraged to engage with the authority, though there is no guarantee of a subsequent formal procurement process or contract awards.

Transitional Drugs 7

Description: This is a contract for the provision of Drugs that have recently lost patent - Eculizumab, Tocilizumab, Nintedanib and Omalizumab

Summary: The NHS Wales Shared Services Partnership - Procurement Services, hosted by Velindre NHS Trust, has initiated an active tender process titled "Transitional Drugs 7." This procurement is centred around the provision of pharmaceutical products, including drugs such as Eculizumab and Tocilizumab, that have lost or are set to lose market exclusivity. The procurement method employed is an open procedure, allowing for broad participation. The tender is valued at approximately £64.28 million gross and is categorised under goods procurement within the pharmaceutical industry. It is expected to be fulfilled throughout Wales, with the contract period commencing on 1st July 2026 and potentially extending until 30th June 2030, considering the renewal options. Key deadlines include an expression of interest deadline on 29th May 2026, with the award period concluding on 8th June 2026.